Valuation: Embracing Future Holdings Limited

Market Cap 67.6M 52.88M 45.74M 42.71M 39.18M 73.7M 5.03B 74.87M 501M 197M 2.52B 199M 194M 8.34B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 69.46M 54.33M 46.99M 43.88M 40.26M 75.72M 5.17B 76.92M 515M 202M 2.59B 204M 200M 8.57B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 day+11.43%
1 week+11.43%
Current month+11.43%
1 month-9.30%
3 months-18.75%
6 months-43.48%
Current year-25.00%
1 week 0.04
Extreme 0.035
0.04
1 month 0.03
Extreme 0.033
0.04
Current year 0.03
Extreme 0.033
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.28
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 2024-04-29
Comptroller/Controller/Auditor 44 2024-06-30
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 2021-06-13
Director/Board Member 55 2023-03-30
Director/Board Member 70 2023-11-26
Date Insider Type Main position Quantity % Market Cap.
4/30/21 Fiscal year

Chairman

330,000 0.1250%
8/19/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
+11.43%+11.43%+56.00%+143.75% 52.88M
+2.41%+3.43%+28.93%+6.88% 220B
+2.39%+5.02%+2.09%-20.96% 144B
+1.36%+7.21%-19.42%+25.07% 134B
+0.02%+5.52%-52.19%-2.51% 71.46B
+0.45%+4.24%+14.51%+14.16% 51.71B
+1.05%+7.19%-14.90%-17.93% 50.84B
+3.28%+5.49%+27.35%+13.73% 41.23B
+1.79%+7.83%+44.69%+37.11% 39.95B
+2.08%+5.51%-0.32%-2.92% 32.42B
Average +2.63%+5.83%+8.67%+19.64% 78.51B
Weighted average by Cap. +1.79%+5.17%+4.11%+4.40%

Financials

2024 2025
Net sales 858K 671K 580K 542K 497K 935K 63.87M 950K 6.36M 2.5M 32.01M 2.52M 2.46M 106M 5.26M 4.11M 3.56M 3.32M 3.05M 5.74M 392M 5.83M 39M 15.31M 196M 15.45M 15.11M 649M
Net income -3.43M -2.69M -2.32M -2.17M -1.99M -3.74M -256M -3.8M -25.45M -9.99M -128M -10.09M -9.87M -424M -3.96M -3.1M -2.68M -2.5M -2.3M -4.32M -295M -4.39M -29.37M -11.53M -148M -11.64M -11.38M -489M
Net Debt 1.46M 1.14M 984K 919K 843K 1.59M 108M 1.61M 10.79M 4.23M 54.29M 4.27M 4.18M 179M 1.86M 1.45M 1.26M 1.17M 1.08M 2.02M 138M 2.06M 13.76M 5.4M 69.25M 5.45M 5.33M 229M
Logo Embracing Future Holdings Limited
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, and Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
26-08-06 SGD 0.0390 +11.43% 89,900
26-08-05 SGD 0.0350 -5.41% 206,400
26-08-03 SGD 0.0370 +5.71% 300
26-07-31 SGD 0.0350 -2.78% 124,100